Your browser doesn't support javascript.
loading
Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer.
Inoue, Hiroto; Todaka, Akiko; Yamazaki, Kentaro; Fushiki, Kunihiro; Shirasu, Hiromichi; Kawakami, Takeshi; Tsushima, Takahiro; Hamauchi, Satoshi; Yokota, Tomoya; Machida, Nozomu; Fukutomi, Akira; Onozawa, Yusuke; Andoh, Akira; Yasui, Hirofumi.
Affiliation
  • Inoue H; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Todaka A; Division of Gastroenterology, Shiga University of Medical Science, Setatsukinowa-tyou, Otsu, Shiga, 520-2192, Japan.
  • Yamazaki K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Fushiki K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan. k.yamazaki@scchr.jp.
  • Shirasu H; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Kawakami T; Division of Medical Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Tsushima T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Hamauchi S; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Yokota T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Machida N; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Fukutomi A; Division of Gastroenterology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa, 241-8515, Japan.
  • Onozawa Y; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Andoh A; Division of Medical Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Yasui H; Division of Gastroenterology, Shiga University of Medical Science, Setatsukinowa-tyou, Otsu, Shiga, 520-2192, Japan.
Invest New Drugs ; 39(5): 1399-1404, 2021 10.
Article in En | MEDLINE | ID: mdl-33835357
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxonic Acid / Biliary Tract Neoplasms / Tegafur / Cisplatin / Deoxycytidine / Antineoplastic Agents Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Invest New Drugs Year: 2021 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxonic Acid / Biliary Tract Neoplasms / Tegafur / Cisplatin / Deoxycytidine / Antineoplastic Agents Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Invest New Drugs Year: 2021 Type: Article Affiliation country: Japan